Heparin-induced thrombocytopenia complicated by warfarin-induced skin necrosis
Case report published in Am J Health Syst Pharm (2008)
Abstract
PURPOSE: A case of heparin-induced thrombocytopenia (HIT) complicated by warfarin-induced skin necrosis (WISN) is reported. SUMMARY: A patient with a history of hypertension, heart failure, and myocardial infarction was admitted to the hospital after complaining of a two-day history of shortness of breath, diaphoresis, and chest pain. The patient underwent a cardiac catheterization and received several medications, including heparin. Suspicions of HIT occurred when her platelets began to decrease severely and she developed a left groin hematoma and a pseudoaneurysm. Lepirudin was initiated and a heparin platelet factor 4 (PF4) antibody test was performed. The results were negative and lepirudin was discontinued. She was rechallenged with unfractionated heparin (UFH) after surgery of the pseudoaneurysm, but her platelets began to decrease again. A second PF4 test was performed, the results of which were positive. The UFH treatment was discontinued. Warfarin was also initiated after surgery and the patient's platelets rapidly increased after heparin was discontinued. She was discharged one week later. Three days after discharge, she was readmitted after complaining of severe pain and swelling of the fatty tissue of her right flank that began the day after she was discharged. Some blistering and necrosis were noted on the lesion. Histological sections showed focal thrombosis of vessels in the deep reticular dermis consistent with WISN. Local wound care was given to manage the WISN, lepirudin was initiated, and warfarin was discontinued and reinstated one week later at a low dosage. CONCLUSION: A patient with HIT developed severe skin necrosis after initiation of warfarin therapy.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
In a patient with HIT confirmed by a second positive PF4 test after heparin rechallenge, warfarin started after surgery was followed by warfarin-induced skin necrosis; lepirudin was used initially and again to manage the necrosis.
Why This Matters for Hirudotherapy
This case report describes a patient who developed heparin-induced thrombocytopenia (HIT) complicated by warfarin-induced skin necrosis (WISN) after cardiac catheterization and heparin exposure. Lepirudin was initiated when HIT was first suspected — later discontinued when the initial PF4 antibody test was negative — and again when WISN developed and warfarin was temporarily discontinued. While lepirudin appears in the clinical management of this case, the abstract does not describe its origin, mechanism, or any connection to leeches or hirudotherapy. The case report centers on the WISN complication rather than leech therapy. Lepirudin is a recombinant derivative of hirudin, the anticoagulant of the medicinal leech (Greinacher, 2004); this paper studies the drug, not leech therapy.
Citation
Reference (Vancouver style)
Howard-Thompson A, Usery JB, Lobo BL, Finch CK. Heparin-induced thrombocytopenia complicated by warfarin-induced skin necrosis. Am J Health Syst Pharm. 2008;65(12):1144-1147. doi:10.2146/ajhp070352. PMID: 18541684
Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.
Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026